InnovAge is trading at $9.26, down 5.41% in after-hours trading; available reporting does not establish a reason for the decline. - Shares closed at $9.79 in the regular session on November 4. - Fiscal first-quarter results on November 3: revenue rose 12.1% to $264.8 million, and adjusted EBITDA increased to $31.3 million. - Management reaffirmed fiscal 2027 revenue guidance of $1.05 billion to $1.085 billion and adjusted EBITDA guidance of $105 million to $115 million.